Our finding that relative hypoirisinemia at sepsis onset and during the first week of sepsis is independently associated with sepsis mortality may have important clinical implications, suggesting that exogenous replacement of irisin early in sepsis may be a promising therapeutic intervention. This evidence concerns the gene FNDC5 and Sepsis.